These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22989771)

  • 41. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mathematical modeling in cancer drug discovery.
    Wang Z; Deisboeck TS
    Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling.
    Karolak A; Estrella VC; Huynh AS; Chen T; Vagner J; Morse DL; Rejniak KA
    Sci Rep; 2018 Feb; 8(1):3638. PubMed ID: 29483578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Target Recognition Molecules and Molecular Modeling Studies.
    Culhaoglu B; Akdemir A
    Curr Top Med Chem; 2017; 17(13):1580-1587. PubMed ID: 28017159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Vitro Validation of Targeting and Comparison to Mathematical Modeling.
    Steinbach-Rankins JM; Caplan MR
    Methods Mol Biol; 2018; 1831():121-141. PubMed ID: 30051429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Look at Receptor-Ligand Pairs for Active-Targeting Drug Delivery from Crystallographic and Molecular Dynamics Perspectives.
    Gocheva G; Ivanova A
    Mol Pharm; 2019 Aug; 16(8):3293-3321. PubMed ID: 31274322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors.
    Namazi H; Kulish VV; Wong A; Nazeri S
    Biomed Res Int; 2016; 2016():8437247. PubMed ID: 27376087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mathematical and computational models of drug transport in tumours.
    Groh CM; Hubbard ME; Jones PF; Loadman PM; Periasamy N; Sleeman BD; Smye SW; Twelves CJ; Phillips RM
    J R Soc Interface; 2014 May; 11(94):20131173. PubMed ID: 24621814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multi-scale modeling of drug binding kinetics to predict drug efficacy.
    Clarelli F; Liang J; Martinecz A; Heiland I; Abel Zur Wiesch P
    Cell Mol Life Sci; 2020 Feb; 77(3):381-394. PubMed ID: 31768605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reconstructed membrane vesicles from the microalga Dunaliella as a potential drug delivery system.
    Levak Zorinc M; Demir-Yilmaz I; Formosa-Dague C; Vrana I; Gašparović B; Horvat L; Butorac A; Frkanec R; Ivošević DeNardis N
    Bioelectrochemistry; 2023 Apr; 150():108360. PubMed ID: 36621049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systems approach for tumor pharmacokinetics.
    Thurber GM; Weissleder R
    PLoS One; 2011; 6(9):e24696. PubMed ID: 21935441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of nanoparticle drug microcarrier on the pharmacokinetics of drug release: a preliminary study.
    Ng EY; Ng WK; Chiam SS
    J Med Syst; 2008 Apr; 32(2):85-92. PubMed ID: 18461811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic interaction between selective drugs in cell populations models.
    Doldán-Martelli V; Míguez DG
    PLoS One; 2015; 10(2):e0117558. PubMed ID: 25671700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical modeling of controlled drug delivery.
    Siepmann J; Peppas NA
    Adv Drug Deliv Rev; 2001 Jun; 48(2-3):137-8. PubMed ID: 11369078
    [No Abstract]   [Full Text] [Related]  

  • 58. A mechanistic approach to modelling the formation of a drug reservoir in the skin.
    Jones JG; White KA; Delgado-Charro MB
    Math Biosci; 2016 Nov; 281():36-45. PubMed ID: 27592115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the generality of the finite element modeling physical fields in biological systems by the multiscale smeared concept (Kojic transport model).
    Kojic M; Milosevic M; Simic V; Milicevic B; Terracciano R; Filgueira CS
    Heliyon; 2024 Mar; 10(5):e26354. PubMed ID: 38434281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mathematical modeling of vesicle drug delivery systems 2: targeted vesicle interactions with cells, tumors, and the body.
    Ying CT; Wang J; Lamm RJ; Kamei DT
    J Lab Autom; 2013 Feb; 18(1):46-62. PubMed ID: 22989771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.